THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMES

HMG-CoA reductase inhibitors (statins) are the most prescribed class of drugs in the world. Some authors suggest that positive effects of statins were reported for statins against pneumonia. These positive studies data were counterbalanced by at least one negative prospective cohort study. Where lie...

Full description

Bibliographic Details
Main Authors: O. Makharynska, N. Zhuravka
Format: Article
Language:English
Published: V. N. Karazin Kharkiv National University 2015-12-01
Series:Journal of V. N. Karazin Kharkiv National University: Series Medicine
Online Access:http://periodicals.karazin.ua/medicine/article/view/5651/5205
_version_ 1811208483844915200
author O. Makharynska
N. Zhuravka
author_facet O. Makharynska
N. Zhuravka
author_sort O. Makharynska
collection DOAJ
description HMG-CoA reductase inhibitors (statins) are the most prescribed class of drugs in the world. Some authors suggest that positive effects of statins were reported for statins against pneumonia. These positive studies data were counterbalanced by at least one negative prospective cohort study. Where lies the truth? Better understanding the statins influence and their potential role in pathophysiological pneumonia mechanisms is needed because of high quantity of subjects receiving statins with numerous medical conditions significantly associated with increased short-term mortality.
first_indexed 2024-04-12T04:22:13Z
format Article
id doaj.art-36d4dec081d8407bba3294c0a173e661
institution Directory Open Access Journal
issn 2313-6693
2313-2396
language English
last_indexed 2024-04-12T04:22:13Z
publishDate 2015-12-01
publisher V. N. Karazin Kharkiv National University
record_format Article
series Journal of V. N. Karazin Kharkiv National University: Series Medicine
spelling doaj.art-36d4dec081d8407bba3294c0a173e6612022-12-22T03:48:11ZengV. N. Karazin Kharkiv National UniversityJournal of V. N. Karazin Kharkiv National University: Series Medicine2313-66932313-23962015-12-01304956THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMESO. MakharynskaN. ZhuravkaHMG-CoA reductase inhibitors (statins) are the most prescribed class of drugs in the world. Some authors suggest that positive effects of statins were reported for statins against pneumonia. These positive studies data were counterbalanced by at least one negative prospective cohort study. Where lies the truth? Better understanding the statins influence and their potential role in pathophysiological pneumonia mechanisms is needed because of high quantity of subjects receiving statins with numerous medical conditions significantly associated with increased short-term mortality.http://periodicals.karazin.ua/medicine/article/view/5651/5205
spellingShingle O. Makharynska
N. Zhuravka
THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMES
Journal of V. N. Karazin Kharkiv National University: Series Medicine
title THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMES
title_full THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMES
title_fullStr THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMES
title_full_unstemmed THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMES
title_short THE EFFECTS OF STATIN THERAPY ON PNEUMONIA OUTCOMES
title_sort effects of statin therapy on pneumonia outcomes
url http://periodicals.karazin.ua/medicine/article/view/5651/5205
work_keys_str_mv AT omakharynska theeffectsofstatintherapyonpneumoniaoutcomes
AT nzhuravka theeffectsofstatintherapyonpneumoniaoutcomes
AT omakharynska effectsofstatintherapyonpneumoniaoutcomes
AT nzhuravka effectsofstatintherapyonpneumoniaoutcomes